The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-nitrobenzo[c][1,2,5]thiadiazole ID: ALA383084
Cas Number: 6583-06-8
PubChem CID: 81062
Product Number: N159774, Order Now?
Max Phase: Preclinical
Molecular Formula: C6H3N3O2S
Molecular Weight: 181.18
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: 4-Nitrobenzo[C][1,2,5]Thiadiazole | 4-Nitro-2,1,3-benzothiadiazole|6583-06-8|4-nitrobenzo[c][1,2,5]thiadiazole|4-Nitro-benzo[1,2,5]thiadiazole|4-Nitropiazthiole|2,1,3-Benzothiadiazole, 4-nitro-|4-Nitro-1,2,3-benzothiadiazole|NSC404747|CHEMBL383084|NSC-404747|WN6H8S4VKP|Oprea1_370043|4-Nitro-2,3-benzothiadiazole|SCHEMBL2213406|4-nitrobenzo-2,1,3-thiadiazole|DTXSID10216019|2,3-Benzothiadiazole, 4-nitro-|IWQKAMJGVIHECB-UHFFFAOYSA-N|HMS3741C11|4-Nitro-2,1, 3-benzothiadiazole|EINECS 229-514-5|BDBM501 Show More⌵
Canonical SMILES: O=[N+]([O-])c1cccc2nsnc12
Standard InChI: InChI=1S/C6H3N3O2S/c10-9(11)5-3-1-2-4-6(5)8-12-7-4/h1-3H
Standard InChI Key: IWQKAMJGVIHECB-UHFFFAOYSA-N
Molfile:
RDKit 2D
12 13 0 0 0 0 0 0 0 0999 V2000
8.8140 1.0286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8128 0.2017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5273 -0.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5255 1.4411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0222 1.2896 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2359 1.0303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2407 0.2017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0309 -0.0485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5118 0.6263 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.5233 2.2661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8089 2.6780 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2371 2.6789 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 7 1 0
1 2 1 0
6 4 1 0
5 6 2 0
7 8 2 0
8 9 1 0
9 5 1 0
4 1 2 0
6 7 1 0
10 11 2 0
10 12 1 0
4 10 1 0
M CHG 2 10 1 12 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 181.18Molecular Weight (Monoisotopic): 180.9946AlogP: 1.60#Rotatable Bonds: 1Polar Surface Area: 68.92Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 2.06CX LogD: 2.06Aromatic Rings: 2Heavy Atoms: 12QED Weighted: 0.49Np Likeness Score: -2.40
References 1. Andricopulo AD, Akoachere MB, Krogh R, Nickel C, McLeish MJ, Kenyon GL, Arscott LD, Williams CH, Davioud-Charvet E, Becker K.. (2006) Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents., 16 (8): [PMID:16458512 ] [10.1016/j.bmcl.2006.01.027 ] 2. Tomek P, Palmer BD, Flanagan JU, Sun C, Raven EL, Ching LM.. (2017) Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions., 126 [PMID:28011425 ] [10.1016/j.ejmech.2016.12.029 ]